Director Mickie Henshall not standing for re-election; board reduces to 7 directors

VOLITIONRX LTD

Mickie Henshall notified board she will not stand for re-election at the 2026 Annual Meeting.
No disagreement with the company on operations, policies, or practices.
Board size reduced from eight to seven directors, effective before the 2026 Annual Meeting.
Ms. Henshall had served on the board since August 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mickie Henshall

Director

VNRX · VOLITIONRX LTD

Filed: May 15, 2026, 4:45 PM ET

On May 12, 2026, Mickie Henshall notified the Board of Directors (the “Board”) of VolitionRx Limited (the “Company”) of her decision not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mickie Henshall departed as Director at VOLITIONRX LTD.

Action: not stand for re-election
Role: Director

Exact text from the filing

On May 12, 2026, Mickie Henshall notified the Board of Directors (the “Board”) of VolitionRx Limited (the “Company”) of her decision not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).

View on SEC.gov

VOLITIONRX LTD filing history →

Source: SEC EDGAR

accession 0001477932-26-003241

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.